Company: INDP
Filing Date: 2025-06-23
Form Type: DEF 14A
Source: 0001641172-25-016071
Chunk: 10

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-23
Form: DEF 14A
Chunk 10
---
 during the meeting that are pertinent to the Company and
the meeting matters, as time permits. Only stockholders admitted to the Special Meeting by following the procedures outlined above in
“Who can attend the Special Meeting?” will be permitted to submit questions during the Special Meeting. Each stockholder
is limited to no more than two questions. Questions should be succinct and only cover a single topic. We will not address questions that
are, among other things:

| ● | irrelevant to the business of the Company or to the business of the 
 Special Meeting;                                                    |

<div align='center'>5</div>

| ● | related to material non-public information of the Company, including                
 the status or results of our business since our last Quarterly Report on Form 10-Q; |
| ● | related to any pending, threatened or ongoing litigation;                           |
| ● | related to personal grievances;                                                     |
| ● | derogatory references to individuals or that are otherwise in bad taste;            |
| ● | substantially repetitious of questions already made by another stockholder;         |
| ● | in excess of the two-question limit;                                                |
| ● | in furtherance of the stockholder’s personal or business interests;                 
 or                                                                                  |
| ● | out of order or not otherwise suitable for the conduct of the Special               
 Meeting as determined by the Chairperson or Secretary in their reasonable judgment. |

How many votes are required for the approval of the proposals to be voted upon and how will abstentions and broker non-votes be treated?

| Proposal                                           |     | Votes required                                                       |     | Effect of Abstentions and Broker Non-Votes                               |
| Proposal 1: Approval of the Issuance Proposal.     |     | The affirmative vote of the holders of a majority in voting power of 
 the votes cast affirmatively or negatively.                          |     | Abstentions will have the same legal effect as a negative vote. A broker 
 non-vote will have no effect.                                            |
| Proposal 2: Approval of the Related Party Proposal |     | The affirmative vote of the holders of a majority in voting power of 
 the votes cast affirmatively or negatively.                          |     | Abstentions will have the same legal effect as a negative vote. A broker 
 non-vote will have no effect.                                            |

What is an “abstention” and how will abstentions be treated?

An “abstention,” represents a stockholder’s
affirmative choice to decline